Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
Nurix Therapeutics (NASDAQ:NRIX) Now Covered by Analysts at BTIG Research
Research analysts at BTIG Research initiated coverage on shares of Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) in a note...
RB Capital Management LLC Acquires New Position in Fidelity National Information Services, Inc. (NYSE:FIS)
RB Capital Management LLC purchased a new stake in shares of Fidelity National Information Services, Inc. (NYSE:FIS – Free Report)...
RB Capital Management LLC Acquires 100 Shares of Agilent Technologies, Inc. (NYSE:A)
RB Capital Management LLC raised its stake in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 6.3% during...
Savoie Capital LLC Purchases New Stake in Lululemon Athletica Inc. (NASDAQ:LULU)
Savoie Capital LLC acquired a new position in Lululemon Athletica Inc. (NASDAQ:LULU – Free Report) during the 3rd quarter, according...
Coldstream Capital Management Inc. Buys 171 Shares of Aflac Incorporated (NYSE:AFL)
Coldstream Capital Management Inc. boosted its stake in Aflac Incorporated (NYSE:AFL – Free Report) by 0.3% in the third quarter,...
Zoetis (NYSE:ZTS) Now Covered by UBS Group
Equities research analysts at UBS Group initiated coverage on shares of Zoetis (NYSE:ZTS – Get Free Report) in a research...